Gene therapy with Adv-IL-2 in unresectable digestive cancer: phase I-II study, intermediate report.
Gilly FN, Beaujard A, Bienvenu J, Trillet Lenoir V, Glehen O, Thouvenot D, Malcus C, Favrot M, Dumontet C, Lombard-Bohas C, Garbit F, Gueugniaud PY, Vignal J, Aymard M, Touraine Moulin F, Roos M, Pavirani A, Courtney M.
Gilly FN, et al. Among authors: favrot m.
Hepatogastroenterology. 1999 May;46 Suppl 1:1268-73.
Hepatogastroenterology. 1999.
PMID: 10429973
Clinical Trial.
No abstract available.